Quetiapine Fumarate
Product Images NDC 53002-2529

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 53002-2529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022529)

Quetiapine Fumarate 50mg extended-release tablets packaging label by RPK Pharmaceuticals, Inc. The label indicates 30 tablets in the unit dose container with directions to take as directed. Includes space for clinic and patient information and Rx-only designation.*

FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

A Kaplan-Meier curve graph showing the proportion of patients with relapse over time in weeks, comparing two groups labeled QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The vertical axis represents the percentage of patients with relapse, and the horizontal axis shows time in weeks, up to 100 weeks.*

FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

A Kaplan-Meier curve illustrating time to recurrence of a mood event over approximately 100 weeks. The y-axis shows the proportion of patients with relapse (%) from 0 to 100, and the x-axis shows time in weeks. Two curves are plotted, one for QTP+ LI/VAL and another for PLA+ LI/VAL, showing differences in relapse proportions over time.*

FDA Label Image

Structure (Quetiapine Stru)

Chemical structure diagram of quetiapine fumarate showing the quetiapine component with its multi-ring system and the fumarate counter ion, depicted twice as indicated by the brackets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.